Matthew Eilerman, Marc E Rothenberg, Lisa J Martin, Ting Wen, Leah C Kottyan, Gurjit K Khurana Hershey, Philip E Putnam, Vincent A Mukkada, Jocelyn M Biagini Myers, Hua He, Jonathan T Kuhl, Nurit P Azouz, Carmy Forney, Melissa K Mingler, Mary C Bedard, Leanne M Ray, Demetria M Fischesser, Mark Rochman, Ayushi Jain, Julie M Caldwell, Mario A Ynga-Durand
Journal: Science translational medicine 2019;10(444):eaap9736
PMID: 29875205
Loss of barrier integrity has an important role in eliciting type 2 immune responses, yet the molecular events that initiate and connect this with allergic inflammation remain unclear. We reveal an endogenous, homeostatic mechanism that controls barrier function and inflammatory responses in esophageal allergic inflammation. We show that a serine protease inhibitor, SPINK7 (serine peptidase inhibitor, kazal type 7), is part of the differentiation program of human esophageal epithelium and that SPINK7 depletion occurs in a human allergic, esophageal condition termed eosinophilic esophagitis. Experimental manipulation strategies reducing in an esophageal epithelial progenitor cell line and primary esophageal epithelial cells were sufficient to induce barrier dysfunction and transcriptional changes characterized by loss of cellular differentiation and altered gene expression known to stimulate allergic responses (for example, and ). Epithelial silencing of promoted production of proinflammatory cytokines including thymic stromal lymphopoietin (TSLP). Loss of increased the activity of urokinase plasminogen-type activator (uPA), which in turn had the capacity to promote uPA receptor-dependent eosinophil activation. Treatment of epithelial cells with the broad-spectrum antiserine protease, α1 antitrypsin, reversed the pathologic features associated with silencing. The relevance of this pathway in vivo was supported by finding genetic epistasis between variants in and the uPA-encoding gene, We propose that the endogenous balance between SPINK7 and its target proteases is a key checkpoint in regulating mucosal differentiation, barrier function, and inflammatory responses and that protein replacement with antiproteases may be therapeutic for select allergic diseases.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Full Text Sources:
Other Literature Sources:
Miscellaneous:
Molecular Biology Databases:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.